Alkermes plc [ALKS] vs Elanco Animal Health [ELAN] Detailed Stock Comparison

Alkermes plc

NASDAQ
Loading...

Elanco Animal Health

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Alkermes plc wins in 15 metrics, Elanco Animal Health wins in 4 metrics, with 0 ties. Alkermes plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAlkermes plcElanco Animal HealthBetter
P/E Ratio (TTM)13.5022.28Alkermes plc
Price-to-Book Ratio3.111.44Elanco Animal Health
Debt-to-Equity Ratio4.4762.13Alkermes plc
PEG Ratio-7.29-0.19Alkermes plc
EV/EBITDA10.2115.93Alkermes plc
Profit Margin (TTM)23.15%9.68%Alkermes plc
Operating Margin (TTM)23.80%6.85%Alkermes plc
EBITDA Margin (TTM)23.80%6.85%Alkermes plc
Return on Equity23.94%6.83%Alkermes plc
Return on Assets (TTM)10.49%0.98%Alkermes plc
Free Cash Flow (TTM)$405.64M$380.00MAlkermes plc
1-Year Return7.90%39.63%Elanco Animal Health
Price-to-Sales Ratio (TTM)3.362.17Elanco Animal Health
Enterprise Value$4.12B$13.41BElanco Animal Health
EV/Revenue Ratio2.742.99Alkermes plc
Gross Profit Margin (TTM)87.34%57.45%Alkermes plc
Revenue per Share (TTM)$9$9Alkermes plc
Earnings per Share (Diluted)$2.27$0.88Alkermes plc
Beta (Stock Volatility)0.491.62Alkermes plc
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Alkermes plc vs Elanco Animal Health Stock Performance Analysis

Loading Price Chart...

Alkermes plc
Elanco Animal Health
Alkermes plc Stock Overview | Elanco Animal Health Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Alkermes plc1.99%15.22%6.33%7.79%-4.26%8.73%
Elanco Animal Health-1.59%8.19%14.68%39.06%90.06%69.88%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Alkermes plc7.90%41.26%85.41%-48.60%96.36%97.72%
Elanco Animal Health39.63%66.69%-38.16%-39.97%-39.97%-39.97%

News Based Sentiment: Alkermes plc vs Elanco Animal Health

Alkermes plc

News based Sentiment: MIXED

October was a month of conflicting signals for Alkermes. While multiple firms upgraded the stock and highlighted the potential of alixorexton, technical indicators pointed towards a potential downturn, and insider selling raised concerns. The upcoming NT2 data release is the key catalyst to watch.

View Alkermes plc News Sentiment Analysis

Elanco Animal Health

News based Sentiment: POSITIVE

Elanco experienced a strong month with a new 52-week high, positive earnings results, and upgrades from multiple analysts. The company is also investing in key areas like automation and high-performance computing, signaling a commitment to future growth. While institutional activity is mixed, the overall narrative is positive.

View Elanco Animal Health News Sentiment Analysis

Performance & Financial Health Analysis: Alkermes plc vs Elanco Animal Health

MetricALKSELAN
Market Information
Market Cap i$5.29B$9.74B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,960,5505,423,590
90 Day Avg. Volume i2,004,0838,718,383
Last Close$31.26$20.47
52 Week Range$25.17 - $36.45$8.02 - $20.92
% from 52W High-14.24%-2.15%
All-Time High$98.50 (Feb 28, 2000)$37.61 (Sep 24, 2018)
% from All-Time High-68.26%-45.57%
Growth Metrics
Quarterly Revenue Growth-0.02%0.05%
Quarterly Earnings Growth-0.05%0.05%
Financial Health
Profit Margin (TTM) i0.23%0.10%
Operating Margin (TTM) i0.24%0.07%
Return on Equity (TTM) i0.24%0.07%
Debt to Equity (MRQ) i4.4762.13
Cash & Liquidity
Book Value per Share (MRQ)$9.84$13.64
Cash per Share (MRQ)$6.15$1.09
Operating Cash Flow (TTM) i$521.00M$572.00M
Levered Free Cash Flow (TTM) i$345.67M$1.21B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Alkermes plc vs Elanco Animal Health

MetricALKSELAN
Price Ratios
P/E Ratio (TTM) i13.5022.28
Forward P/E i15.2520.86
PEG Ratio i-7.29-0.19
Price to Sales (TTM) i3.362.17
Price to Book (MRQ) i3.111.44
Market Capitalization
Market Capitalization i$5.29B$9.74B
Enterprise Value i$4.12B$13.41B
Enterprise Value Metrics
Enterprise to Revenue i2.742.99
Enterprise to EBITDA i10.2115.93
Risk & Other Metrics
Beta i0.491.62
Book Value per Share (MRQ) i$9.84$13.64

Financial Statements Comparison: Alkermes plc vs Elanco Animal Health

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ALKSELAN
Revenue/Sales i$306.51M$1.24B
Cost of Goods Sold i$49.20M$528.00M
Gross Profit i$257.31M$713.00M
Research & Development i$71.82M$92.00M
Operating Income (EBIT) i$13.79M$85.00M
EBITDA i$32.91M$243.00M
Pre-Tax Income i$25.49M$25.00M
Income Tax i$3.03M$14.00M
Net Income (Profit) i$22.46M$11.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ALKSELAN
Cash & Equivalents i$399.81M$539.00M
Total Current Assets i$1.48B$3.61B
Total Current Liabilities i$443.73M$1.39B
Long-Term Debt i$67.81M$4.15B
Total Shareholders Equity i$1.51B$6.78B
Retained Earnings i$-953.99M$-1.87B
Property, Plant & Equipment i$82.41MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ALKSELAN
Operating Cash Flow i$122.31M$185.00M
Capital Expenditures i$-8.40M$-57.00M
Free Cash Flow i$88.70M$180.00M
Debt Repayment i$0$-446.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricALKSELAN
Shares Short i15.06M27.38M
Short Ratio i7.582.68
Short % of Float i0.13%0.08%
Average Daily Volume (10 Day) i1,960,5505,423,590
Average Daily Volume (90 Day) i2,004,0838,718,383
Shares Outstanding i162.18M494.45M
Float Shares i162.42M492.94M
% Held by Insiders i0.01%0.01%
% Held by Institutions i1.05%1.10%

Dividend Analysis & Yield Comparison: Alkermes plc vs Elanco Animal Health

MetricALKSELAN
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A